Back to results
US 2004/0002509 A1Published application
Novel substituted imidazole compounds
AssigneeSmithKline Beecham Corporation
InventorJerry L. Adams
Life of this patent
Estimating the term…
Abstract
Novel 1,4,5-substituted imidazole compounds and compositions for use in therapy as ERK/MAP inhibitors of ERK/MAP mediated diseases.
Claims8
A compound represented by the formula:
- 4
- wherein
- R1 is hydrogen, halogen, C1-5 alkyl, C1-5 alkoxy, or arylC1-5 alkyl;
- R2 is hydrogen, C1-5 alkyl, aryl, arylC1-5 alkyl, heteroaryl, heteroarylC1-5 alkyl, heterocyclic, or heterocyclic C1-5alkyl, and wherein all of these moieties may be optionally substituted;
- R3 is hydrogen, or C1-3 alkyl;
- R4 is hydrogen, C1-5 alkyl, aryl, arylC1-5 alkyl, heteroaryl, heteroarylC1-5 alkyl, heterocyclic, or heterocyclic C1-5 alkyl, and wherein all of these moieties may be optionally substituted;
- or a pharmaceutically acceptable salt thereof.
4 more elements
Dependencies are inferred from the claim text.